News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)


10/1/2007 8:36:22 AM

CHESTER, N.J., Oct. 1 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT - News) today announced that the Food and Drug Administration (FDA) approved its supplemental New Drug Application for a grape-flavored formulation of Delsym Extended-Release Suspension on Friday, Sept. 28, 2007. The Company will immediately commence distribution of grape Delsym product to its trade customers.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES